These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 118827)

  • 1. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostatic adenocarcinoma. Chemotherapy of autonomous tumor, 102 Pr, heterotransplanted into congenitally athymic (nude) mice and syngeneic Nb rats.
    Drago JR; Maurer RE; Goldman LB; Gershwin ME
    Cancer Chemother Pharmacol; 1979; 3(3):167-70. PubMed ID: 118827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of Nb rat adenocarcinoma of the prostate heterotransplanted into congenitally athymic (nude) mice: report of 5-fluorouracil and cyclophosphamide.
    Drago JR; Maurer RE; Gershwin ME; Eckels DD; Goldman LB
    J Surg Res; 1979 Apr; 26(4):400-3. PubMed ID: 431058
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterotransplantation of Nb rat prostatic adenocarcinomas into congenitally athymic nude mice.
    Drago JR; Gershwin ME
    Cancer; 1981 Jan; 47(1):55-9. PubMed ID: 7193077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 5-fluorouracil and adriamycin on heterotransplantation of Noble rat prostatic tumors in congenitally athymic (nude) mice.
    Drago JR; Maurer RE; Gershwin ME; Eckels D; Palmer JM
    Cancer; 1979 Aug; 44(2):424-30. PubMed ID: 476560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy for Nb rat tumor transplanted in athymic mice.
    Drago JR; Goldman LB; Worgul T; Gershwin ME
    J Surg Oncol; 1981; 16(3):265-72. PubMed ID: 7218811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostate adenocarcinoma into congenitally athymic (nude) mice. I. Hormone dependency and histopathology.
    Drago JR; Gershwin ME; Maurer RE; Ikeda RM; Eckels DD
    J Natl Cancer Inst; 1979 Apr; 62(4):1057-66. PubMed ID: 285279
    [No Abstract]   [Full Text] [Related]  

  • 7. The Nb rat prostatic adenocarcinoma model system.
    Drago JR; Goldman LB; Maurer RE
    Prog Clin Biol Res; 1980; 37():265-91. PubMed ID: 7384086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
    Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
    Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation and metastasis of NB rat prostate neoplasia in congenitally athymic (nude) mice, nude mice treated with antilymphocyte sera and congenitally athymic rats.
    Gershwin ME; Ruebner BH; Ikeda RM
    Exp Cell Biol; 1982; 50(3):145-54. PubMed ID: 7095249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
    Drago JR; Goldman LB; Gershwin ME
    Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy and radiation of Nb rat prostatic adenocarcinoma: Nb Pr-A.I.-1.
    Drago JR; Goldman L; Gershwin ME
    J Surg Res; 1980 Jun; 28(6):492-6. PubMed ID: 7421169
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III.
    Drago JR
    J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic and hormonal considerations of the Nb rat prostatic adenocarcinoma model.
    Drago JR; Goldman LB; Gershwin ME
    Prog Clin Biol Res; 1980; 37():325-63. PubMed ID: 7384092
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of the Nb rat in combination chemotherapeutic experiments for prostate cancer.
    Drago JR; Smith J
    In Vivo; 1991; 5(1):41-2. PubMed ID: 1932624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
    Drago JR; Worgul T
    Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nb rat: prostatic adenocarcinoma model.
    Drago JR; Ikeda RM; Maurer RE; Goldman LB; Tesluk H
    Invest Urol; 1979 Mar; 16(5):353-9. PubMed ID: 429131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat (Pr-90) prostatic carcinoma.
    Drago JR; Goldman LB
    Cancer; 1980 Feb; 45(4):757-63. PubMed ID: 7357493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis in the androgen-insensitive Nb rat prostatic carcinoma system.
    Drago JR; Lombard JS
    J Surg Oncol; 1985 Apr; 28(4):252-6. PubMed ID: 4039015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin.
    Giuliani FC; Zirvi KA; Kaplan NO; Goldin A
    Int J Cancer; 1981 Jan; 27(1):5-13. PubMed ID: 7251230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.